FDA approves TMS as form of OCD treatment

The FDA has approved Neuronetics’ transcranial magnetic stimulation system, called NeuroStar, as an adjunct treatment for adults with obsessive compulsive disorder.
Neuronetics created NeuroStar as the first FDA-approved TMS system pioneered for major depressive disorder, the company said in a press release. With the new FDA approval, it will allow physicians to treat patients with OCD, as well as those with MDD, without the need for additional hardware.
“This new indication means that NeuroStar can help even more people suffering from mental health disorders that can be